Refereed journal article or data article (A1)

The role of the maleimide ring system on the structure-activity relationship of showdomycin




List of Authors: Rosenqvist Petja, Mäkinen Janne J, Palmu Kaisa, Jokinen Johanna, Prajapati Ranjit K, Korhonen Heidi J, Virta Pasi, Belogurov Georgiy A, Metsä-Ketelä Mikko

Publisher: Elsevier

Publication year: 2022

Journal: European Journal of Medicinal Chemistry

Journal name in source: European journal of medicinal chemistry

Journal acronym: Eur J Med Chem

Volume number: 237

ISSN: 0223-5234

eISSN: 1768-3254

DOI: http://dx.doi.org/10.1016/j.ejmech.2022.114342

URL: https://doi.org/10.1016/j.ejmech.2022.114342

Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/175186915


Abstract

Showdomycin produced by Streptomyces showdoensis ATCC 15227 is a C-nucleoside microbial natural product with antimicrobial and cytotoxic properties. The unique feature of showdomycin in comparison to other nucleosides is its maleimide base moiety, which has the distinct ability to alkylate nucleophilic thiol groups by a Michael addition reaction. In order to understand structure-activity relationships of showdomycin, we synthesized a series of derivatives with modifications in the maleimide ring at the site of alkylation to moderate its reactivity. The showdomycin congeners were designed to retain the planarity of the base ring system to allow Watson-Crick base pairing and preserve the nucleosidic character of the compounds. Consequently, we synthesized triphosphates of showdomycin derivatives and tested their activity against RNA polymerases. Bromo, methylthio, and ethylthio derivatives of showdomycin were incorporated into RNA by bacterial and mitochondrial RNA polymerases and somewhat less efficiently by the eukaryotic RNA polymerase II. Showdomycin derivatives acted as uridine mimics and delayed further extension of the RNA chain by multi-subunit, but not mitochondrial RNA polymerases. Bioactivity profiling indicated that the mechanism of action of ethylthioshowdomycin was altered, with approximately 4-fold reduction in both cytotoxicity against human embryonic kidney cells and antibacterial activity against Escherichia coli. In addition, the ethylthio derivative was not inactivated by medium components or influenced by addition of uridine in contrast to showdomycin. The results explain how both the maleimide ring and the nucleoside nature contribute to the bioactivity of showdomycin and demonstrates for the first time that the two activities can be separated.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Last updated on 2022-16-05 at 09:28